Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 16
2004 3
2005 7
2006 11
2007 8
2008 2
2009 8
2010 15
2011 9
2012 8
2013 8
2014 6
2015 9
2016 5
2017 4
2018 4
2019 5
2020 7
2021 6
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM. Zhao N, et al. Among authors: rosen jm. J Clin Invest. 2023 Dec 15;133(24):e172503. doi: 10.1172/JCI172503. J Clin Invest. 2023. PMID: 37874652 Free PMC article.
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer.
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, Zhou J, Solis LM, Hilsenbeck SG, Fan C, Perou CM, Rosen JM. Zhao N, et al. Among authors: rosen jm. bioRxiv [Preprint]. 2023 Sep 28:2023.09.28.559973. doi: 10.1101/2023.09.28.559973. bioRxiv. 2023. PMID: 37808840 Free PMC article. Updated. Preprint.
The tumor-immune ecosystem in shaping metastasis.
Gao Y, Rosen JM, Zhang XH. Gao Y, et al. Among authors: rosen jm. Am J Physiol Cell Physiol. 2023 Mar 1;324(3):C707-C717. doi: 10.1152/ajpcell.00132.2022. Epub 2023 Jan 30. Am J Physiol Cell Physiol. 2023. PMID: 36717100 Free PMC article. Review.
LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells.
Ngai H, Barragan GA, Tian G, Balzeau JC, Zhang C, Courtney AN, Guo L, Xu X, Wood MS, Drabek JM, Demberg T, Sands CM, Chauvin-Fleurence CN, Di Pierro EJ, Rosen JM, Metelitsa LS. Ngai H, et al. Among authors: rosen jm. Cancer Immunol Res. 2023 Feb 3;11(2):171-183. doi: 10.1158/2326-6066.CIR-22-0333. Cancer Immunol Res. 2023. PMID: 36484736 Free PMC article.
Mechanisms of cancer metastasis.
Castaneda M, den Hollander P, Kuburich NA, Rosen JM, Mani SA. Castaneda M, et al. Among authors: rosen jm. Semin Cancer Biol. 2022 Dec;87:17-31. doi: 10.1016/j.semcancer.2022.10.006. Epub 2022 Oct 27. Semin Cancer Biol. 2022. PMID: 36354098 Free article. Review.
STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential.
Lin M, Ku AT, Dong J, Yue F, Jiang W, Ibrahim AA, Peng F, Creighton CJ, Nagi C, Gutierrez C, Rosen JM, Zhang XH, Hilsenbeck SG, Chen X, Du YN, Huang S, Shi A, Fan Z, Li Y. Lin M, et al. Among authors: rosen jm. Oncogene. 2022 Nov;41(48):5214-5222. doi: 10.1038/s41388-022-02500-w. Epub 2022 Oct 19. Oncogene. 2022. PMID: 36261627 Free PMC article.
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.
Singh S, Lee N, Pedroza DA, Bado IL, Hamor C, Zhang L, Aguirre S, Hu J, Shen Y, Xu Y, Gao Y, Zhao N, Chen SH, Wan YW, Liu Z, Chang JT, Hollern D, Perou CM, Zhang XHF, Rosen JM. Singh S, et al. Among authors: rosen jm. Cancer Res. 2022 Jun 15;82(12):2281-2297. doi: 10.1158/0008-5472.CAN-21-3714. Cancer Res. 2022. PMID: 35442423 Free PMC article.
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeutics.
Gao Y, Kabotyanski EB, Shepherd JH, Villegas E, Acosta D, Hamor C, Sun T, Montmeyor-Garcia C, He X, Dobrolecki LE, Westbrook TF, Lewis MT, Hilsenbeck SG, Zhang XH, Perou CM, Rosen JM. Gao Y, et al. Among authors: rosen jm. Cancer Res Commun. 2021 Dec;1(3):178-193. doi: 10.1158/2767-9764.crc-21-0106. Epub 2021 Dec 27. Cancer Res Commun. 2021. PMID: 35156101 Free PMC article.
150 results